International Trachoma Initiative
Goal:To eliminate trachoma, the world's leading cause of preventable blindness
Targeted Area: The developing world
Start Date: 1998
Pfizer's Commitment: Donations of the antibiotic Zithromax® (azithromycin) and support for community-based training and education initiatives
Partners: Task Force for Child Survival and Development, World Health Organization, Gates Foundation, Carter Center, Lions Club International, USAID, and the Edna McConnell Clark Foundation among others
Successes:
To view this interactive feature, you must have Flash 9 installed on your computer.
If you do not have Flash 9, you can download it from the Adobe web site.
- More than 145 million treatments of Zithromax® donated for use in 18 countries
- More than 416,000 surgeries performed to treat advanced cases of trichiasis, the advanced and blinding stage of trachoma
- Thousands of health care workers trained in trachoma treatment
- In 2006, Morocco became the first country to complete the campaign for trachoma control and is working toward WHO certification that blinding trachoma has been eliminated as a public health problem.
 |
If you do not have Adobe® Reader, download it here. It is available without charge from Adobe®. This link is provided as a convenience. Pfizer is not responsible for the content of this linked page. |
Learn more about International Trachoma Initiative.
- Visit www.trachoma.org
- View the Morocco: A Brighter Future in Sight booklet
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2010 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
